P149\u2005Telehealth and access to medications in an era of COVID-19. Experience from virtual clinics for patients with severe asthma on biologics

Abstract

P149 Table 1Patient perceptions on availability of medications, telemedicine and biologic therapyStatement Strongly Disagree Disagree Neutral Agree Strongly Agree Asthma improved with biologic 4 3 2 8 37 Sufficient medications 7 9 3 11 24 Difficulty obtaining medication 21 9 7 10 17 Satisfied with telemedicine 2 3 18 14 17 ConclusionsMany patients were satisfied with telemedicine, so this could be used to deliver routine outpatient tertiary care post-pandemic However, during the lockdown, some patients did not receive scheduled biologic therapy and had insufficient medications Thus, logistics around supplying medications, and biologics must be considered in plans preparing for a second wave of COVID-19 Teaching patients to self-inject biologic therapy should be considered